X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15567) 15567
Publication (1681) 1681
Newspaper Article (959) 959
Book / eBook (546) 546
Newsletter (300) 300
Magazine Article (233) 233
Book Review (197) 197
Book Chapter (107) 107
Report (59) 59
Trade Publication Article (48) 48
Government Document (46) 46
Conference Proceeding (45) 45
Web Resource (25) 25
Dissertation (7) 7
Paper (7) 7
Data Set (3) 3
Journal / eJournal (2) 2
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12879) 12879
index medicus (7229) 7229
female (5845) 5845
oncology (5204) 5204
male (4394) 4394
chemotherapy (4386) 4386
cancer (4223) 4223
middle aged (3817) 3817
adult (3397) 3397
aged (3188) 3188
standards (2462) 2462
care and treatment (2382) 2382
research (2014) 2014
treatment outcome (2005) 2005
standard deviation (1585) 1585
surgery (1461) 1461
prognosis (1434) 1434
patients (1413) 1413
health aspects (1403) 1403
pharmacology & pharmacy (1393) 1393
aged, 80 and over (1373) 1373
hematology (1312) 1312
analysis (1270) 1270
antineoplastic combined chemotherapy protocols - therapeutic use (1255) 1255
adolescent (1239) 1239
united states (1193) 1193
breast cancer (1157) 1157
retrospective studies (1136) 1136
therapy (1120) 1120
diagnosis (1118) 1118
survival (1115) 1115
tumors (1016) 1016
child (1009) 1009
studies (1003) 1003
practice guidelines as topic (976) 976
risk factors (973) 973
cancer therapies (970) 970
microbiology (968) 968
neoplasm staging (961) 961
antineoplastic agents - therapeutic use (960) 960
medicine (943) 943
radiotherapy (935) 935
infectious diseases (920) 920
animals (911) 911
management (909) 909
reproducibility of results (900) 900
usage (891) 891
clinical trials (874) 874
quality of life (874) 874
medicine, general & internal (838) 838
hospitals (834) 834
methods (811) 811
metastasis (778) 778
medical research (733) 733
nursing (724) 724
neoplasms - drug therapy (723) 723
research article (718) 718
health care sciences & services (711) 711
drug therapy (704) 704
combined modality therapy (699) 699
medicine & public health (691) 691
young adult (690) 690
carcinoma (687) 687
time factors (686) 686
survival analysis (684) 684
hematology, oncology and palliative medicine (683) 683
prospective studies (677) 677
follow-up studies (659) 659
stockholders (650) 650
survival rate (642) 642
mortality (640) 640
neoplasms - therapy (632) 632
drugs (612) 612
sensitivity and specificity (596) 596
radiology, nuclear medicine & medical imaging (594) 594
child, preschool (592) 592
disease-free survival (580) 580
surveys and questionnaires (573) 573
breast-cancer (571) 571
reference standards (558) 558
transplantation (545) 545
medical oncology - standards (535) 535
antineoplastic agents - adverse effects (530) 530
quality control (529) 529
trial (524) 524
children (514) 514
guidelines (511) 511
patient outcomes (510) 510
abridged index medicus (507) 507
standard (506) 506
breast neoplasms - pathology (503) 503
pathology (497) 497
article (491) 491
oncology, experimental (484) 484
disease (481) 481
boards of directors (475) 475
medicine, research & experimental (475) 475
medical prognosis (467) 467
pediatrics (466) 466
antineoplastic agents (463) 463
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (326) 326
Robarts - Stacks (29) 29
Collection Dvlpm't (Acquisitions) - Closed Orders (28) 28
UofT at Mississauga - Stacks (27) 27
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (23) 23
UTL at Downsview - May be requested (19) 19
Law (Bora Laskin) - Stacks (16) 16
UofT at Scarborough - Stacks (16) 16
Markham Stouffville Hospital - Stacks (13) 13
St. Michael's College (John M. Kelly) - 2nd Floor (13) 13
Providence Healthcare - Stacks (12) 12
Humber River Regional Hospital - Church Stacks (11) 11
Scarborough Hospital - General (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (10) 10
West Park Healthcare Centre - Stacks (9) 9
Baycrest Hospital - Stacks (8) 8
Lakeridge Health Sciences - Oshawa (8) 8
Engineering & Comp. Sci. - Stacks (7) 7
Holland Bloorview Kids Rehabilitation - Stacks (7) 7
Toronto East General Hospital - Stacks (7) 7
Scarborough Hospital - Birchmount (6) 6
Credit Valley Hospital - Stacks (5) 5
Humber River Regional Hospital - Finch Stacks (4) 4
OISE - Stacks (4) 4
St. Augustine's Seminary - Stacks (4) 4
Criminology - Stacks (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
Gerstein Science - Reference (3) 3
New College (Ivey) - Stacks (3) 3
Providence Healthcare - Reference (3) 3
Regis College - Stacks (3) 3
Trinity College (John W Graham) - Stacks (3) 3
Victoria University E.J. Pratt - Reference (3) 3
Gerstein Science - Not Returned (2) 2
Pharmacy (2) 2
Scarborough Hospital - Missing (2) 2
St Josephs Health Centre - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
Trinity College (John W Graham) - Reference (2) 2
University College (Laidlaw) - Stacks (2) 2
UofT at Mississauga - Reference (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Reference (1) 1
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Chemistry (A D Allen) - Reference (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Faculty of Information - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Closed Orders (1) 1
Gerstein Science - Missing (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Keele Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
OISE - Curriculum Resources (1) 1
OISE - May be requested in 6-10 wks (1) 1
Physics - Reference (1) 1
Scarborough Hospital - Hospital Department (1) 1
Scarborough Hospital - Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Periodical Stacks (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
Victoria University E.J. Pratt - Internal dept (1) 1
Victoria University Emmanuel College - Reference (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17024) 17024
Japanese (364) 364
French (175) 175
German (121) 121
Spanish (36) 36
Russian (24) 24
Chinese (20) 20
Dutch (18) 18
Portuguese (17) 17
Hungarian (13) 13
Polish (10) 10
Korean (7) 7
Italian (6) 6
Norwegian (6) 6
Danish (4) 4
Arabic (2) 2
Czech (2) 2
Finnish (2) 2
Afrikaans (1) 1
Croatian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 02/2019, Volume 94, Issue 2, pp. 209 - 215
An intensive “5 + 1” regimen, which included bolus high dose cytarabine (HiDAC) at 3 g/m2 once daily over 3 hours on days 1‐5 and high dose mitoxantrone (HDM)... 
SURVIVAL | INTENSIVE CHEMOTHERAPY | THERAPY | EARLY DEATH | OLDER PATIENTS | RANDOMIZED-TRIAL | TRANSPLANTATION COMORBIDITY INDEX | CYTARABINE | DAUNORUBICIN | HEMATOLOGY | STANDARD
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 10/2011, Volume 17, Issue 10, pp. 1478 - 1483
Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure that treatments effective in... 
Cutaneous leishmaniasis | standardization | drug sensitivity | HIV co-infection | visceral leishmaniasis | HIV co‐infection | Visceral leishmaniasis | Drug sensitivity | Standardization | INFECTIOUS DISEASES | ORAL MILTEFOSINE | EFFICACY | RANDOMIZED-TRIAL | MICROBIOLOGY | DRUG-RESISTANCE | LIPOSOMAL AMPHOTERICIN-B | INDIAN VISCERAL LEISHMANIASIS | AZAR DERMAL LEISHMANIASIS | IN-VIVO | WORLD CUTANEOUS LEISHMANIASIS | DOUBLE-BLIND | Coinfection - drug therapy | Humans | Research - organization & administration | Coinfection - parasitology | Anti-HIV Agents - administration & dosage | Leishmaniasis, Cutaneous - epidemiology | Anti-HIV Agents - therapeutic use | Leishmaniasis, Visceral - parasitology | Clinical Trials as Topic - standards | Paromomycin - therapeutic use | HIV Infections - virology | Paromomycin - administration & dosage | India - epidemiology | Leishmaniasis, Cutaneous - drug therapy | HIV - pathogenicity | Coinfection - virology | Drug Discovery | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Cutaneous - parasitology | Antiprotozoal Agents - administration & dosage | HIV Infections - drug therapy | HIV Infections - parasitology | Leishmania - pathogenicity | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - epidemiology | Chemotherapy | Leishmaniasis | Universities and colleges | HIV (Viruses) | Analysis | Cancer | Research & development--R&D | Parasitic diseases
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2016, Volume 43, Issue 12, pp. 2105 - 2113
Journal Article
Journal Article
1999, ISBN 0127753907, xxiv, 1136 p., [8] p. of plates
Handbook of Animal Models of Infection is a complete revision of a three-volume text that was published in 1986. It incorporates the major advances in the... 
Infection | Anti-infective agents | animal models | Animal models in research | Communicable diseases | Diseases | Clinical & internal medicine | Evaluation | Chemotherapy | Animal models
Book
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. e191 - e199
Although chemotherapy is a well established treatment modality, chemotherapy errors represent a potentially serious risk of patient harm. We reviewed published... 
PHYSICIAN ORDER ENTRY | CANCER-CHEMOTHERAPY | ONCOLOGY | ORAL CHEMOTHERAPY | PEDIATRIC ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HEALTH-CARE | PRESCRIPTION ERRORS | OF-THE-LITERATURE | ADMINISTRATION SAFETY STANDARDS | ADVERSE EVENTS | Medical colleges | Chemotherapy | Hospitals | Oncology, Experimental | Pharmacy | Research | Medication errors | Cancer
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2013, Volume 60, Issue 3, pp. 409 - 414
Background The aims of this study were to determine the feasibility of the combination of low dose, anti‐angiogenic chemotherapy with standard therapy for... 
antiangiogenic agents | Ewing sarcoma | cystitis | radiation pneumonitis | Cystitis | Antiangiogenic agents | Radiation pneumonitis | CLINICAL-TRIAL | CELECOXIB | PULMONARY METASTASES | CELL LUNG-CANCER | PRIMITIVE NEUROECTODERMAL TUMOR | IRRADIATION | THERAPY | ONCOLOGY | INDUCED HEMORRHAGIC CYSTITIS | PEDIATRICS | BONE | HEMATOLOGY | CARDIOVASCULAR RISK | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Male | Sarcoma, Ewing - mortality | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Vinblastine - pharmacokinetics | Young Adult | Angiogenesis Inhibitors - administration & dosage | Vinblastine - adverse effects | Angiogenesis Inhibitors - therapeutic use | Female | Pyrazoles - pharmacokinetics | Child | Doxorubicin - administration & dosage | Pyrazoles - adverse effects | Etoposide - adverse effects | Ifosfamide - adverse effects | Etoposide - administration & dosage | Angiogenesis Inhibitors - pharmacokinetics | Combined Modality Therapy | Celecoxib | Radiotherapy | Sulfonamides - pharmacokinetics | Sarcoma, Ewing - drug therapy | Disease-Free Survival | Pilot Projects | Pyrazoles - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sulfonamides - adverse effects | Doxorubicin - adverse effects | Sarcoma, Ewing - radiotherapy | Sulfonamides - administration & dosage | Medical research | Care and treatment | Pneumonia | Anthracyclines | Sarcoma | Bacterial pneumonia | Children's hospitals | Metastasis | Standards | Cyclophosphamide | Chemotherapy | Nuclear radiation | Medicine, Experimental | Dosage and administration | Cancer | Index Medicus
Journal Article